Enhancement of nonspecific resistance to microbial infections of synthetic lipid a-subunit analogues of GLA-27 modified at the C1 position of the glucosamine backbone

This publication has 22 references indexed in Scilit:

• Enhancement of nonspecific resistance to bacterial infections and tumor regressions by treatment with synthetic lipid A-subunit analogs. Critical role of N- and 3-O-linked acyl groups in derivatives
  International Journal of Immunopharmacology, 1989
• Enhancement of nonspecific resistance to viral infection by chemically synthesized lipid A-subunit analogs with different backbone structures and acyl groups
  Antiviral Research, 1988
• Effect of chemical modification at C1 of the glucosamine backbone of lipid A-subunit analog GLA-27 on manifestation of immunopharmacological activity
  FEBS Letters, 1988
• Antiviral and immunomodulating activities of chemically synthesized lipid A-subunit analogues GLA-27 and GLA-60
  Antiviral Research, 1988
• Effect of stereospecificity of chemically synthesized lipid A‐subunit analogues GLA‐27 and GLA‐40 on the expression of immunopharmacological activities
  European Journal of Immunology, 1987
• Effects of Backbone Structures and Stereospecificities of Lipid A-Subunit Analogues on Their Biological Activities1
  The Journal of Biochemistry, 1986
• Structural requirements for inducing in vitro B lymphocyte activation by chemically synthesized derivatives related to the nonreducing D‐glucosamine subunit of lipid A
  European Journal of Immunology, 1986
• Enhancement of non-specific resistance to viral infection by muramyldipeptide and its analogs
  Antiviral Research, 1985
• B cell activation and adjuvant activities of chemically synthesized analogues of the nonreducing sugar moiety of lipid A
  European Journal of Immunology, 1985
• Biological activities of chemically synthesized analogues of the nonreducing sugar moiety of lipid A
  FEBS Letters, 1984